Creabilis expands senior management team
This article was originally published in Scrip
Earlier in August, Creabilis hired David Roblin from Pfizer as chief medical officer (scripintelligence.com, 9 August), and now, the company has appointed three more ex-Pfizer employees to its senior management team. Alex Leech joins Creabilis as vice-president and head of finance and operations, and previously served as head of operations at Solace Pharmaceuticals, and head of European project management for the Pfizer R&D organisation. James Sandy was most recently development team leader at Pfizer, and joins Creabilis as senior vice-president and head of development, and Dr Peter Spargo, former head of chemical process R&D for Pfizer, joins as senior vice-president of CMC, the same role he held recently at Novexel.